# A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

> **NCT00504192** · PHASE2 · COMPLETED · sponsor: **Soonchunhyang University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Advanced Biliary Tract Adenocarcinoma
- Gemcitabine
- Oxaliplatin
- Combination Chemotherapy
- Efficacy

## Interventions

- **DRUG:** Gemcitabine and Oxaliplatin

## Key facts

- **NCT ID:** NCT00504192
- **Lead sponsor:** Soonchunhyang University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-03
- **Final completion:** 2009-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504192, "A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00504192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*